Arca
Skip to content

The Natus Cranial Access Kit is designed to be a complete

Recall Z-0735-2023, part of FDA recall event 91193. See Natus Medical's company page.

Natus Medical Incorporated started this Class II device recall on Nov 18, 2022 (voluntary: firm initiated); FDA lists it as ongoing.

  • Classification: Class II
  • Started: Nov 18, 2022
  • Status: Ongoing

Why It Was Recalled

Class II

Due to Cranial Access Kits containing recalled sterile surgical drapes. The sterile surgical drapes are being recalled due to the liner on the adhesive component is difficult to remove without damaging the product and may render the product unusable.

Record

Product
The Natus Cranial Access Kit is designed to be a complete, single use and disposable accessory and instrumentation set that is used to create an intracranial burr-hole typically required for procedures such as ventriculostomy or intracranial pressure (ICP) monitoring. The various components of the kit are comprised to make it convenient for the practitioner to have all that they need in one place for fast and efficient intracranial access. cerebral spinal fluid (CSF).
Quantity
249 kits
Lots and codes
Part Number: HITH1 UDI-DI Code: 382830048590 Lot Number: 22GDB675 Part Number: HITHNDRZR UDI-DI Code: 382830048620 Lot Number: 22HDA557 Part Number: HITHLT UDI-DI Code: 382830048637 Lot Number: 22IDB724
Distribution
U.S. Nationwide distribution in the states of AK, CA, CT, DC, FL, GA, IA, ID, IL, KS , MD, MI, MT, ND, NE, NJ, NV, NY, OH, OR, TX, and WA.
Recalling firm
Natus Medical Incorporated, San Diego, CA, United States
How the firm notified
Letter
FDA classified
Dec 20, 2022

Natus Medical Incorporated's Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.